MarketLens
Sign Up

What Did Arcus Biosciences Highlight at the Goldman Sachs Healthcare Conference

4 months ago
SHARE THIS ON:

What Did Arcus Biosciences Highlight at the Goldman Sachs Healthcare Conference

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Arcus Biosciences presented at Citigroup's Biopharma Back to School Summit 2026, discussing pipeline updates. No financial figures or guidance changes were disclosed in the transcript.
Stock News•2 months ago

ArriVent BioPharma: Firmonertinib Delay Strengthens The Upside Case

ArriVent BioPharma's Firmonertinib readout moved to H2 2026, likely reflecting slower event accumulation and longer progression-free survival. The drug remains the core value driver, with pipeline exp...
Stock News•3 months ago

Why Did This Arcus Biosciences Analyst Bump Price Forecast by 33%?

HC Wainwright raised its Arcus Biosciences price target by 33%, citing the company's aggressive push into first-line clear cell renal cell carcinoma development.

Breaking News

View All →

Top Headlines

View More →
Stock News•26 minutes ago

Google parent Alphabet suffers nearly $500B Wall Street wipeout amid AI spending fears

Stock News•53 minutes ago

Amazon the Latest Mag 7 to Miss Q3 Estimates

Stock News•1 hour ago

20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"

Stock News•1 hour ago

Microsoft Q1: Capex Shouldn't Scare You Due To Free Cash Flow

Stock News•1 hour ago

Microsoft Took The Balanced Approach To AI - Now It's The King